BiosimilarsCanadian HealthcareDrug Policy
All Canadian Provinces Now Require Biosimilar Switching
On August 1, 2024, Manitoba became the last Canadian province to implement a biosimilar transition policy for its public drug plan. With this move, all ten provinces now require patients using certain o
PlusVirtual TeamAug 19, 2024